Bone Biologics Corporation BBLG
0.37 USD -0.01 -2.52%
At close · Nov 2
0.37 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
- YTD
- -74.43%
- 1 year
- -82.59%
- Open
- 0.3848
- Prev close
- 0.3804
- Mkt cap
- 1.26M
- Vol
- 23.89K
- Avg vol
- 380.70K
- EPS
- -1.02
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.3667
- High
- 0.3884
- Forward P/E
- -0.41
- Beta
- 0.74
- Short ratio
- 0.18
- Inst. own
- 4.59%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2024
- 50-d avg
- 1.34
- 200-d avg
- 1.60
- 1y target
- 16.75
MAX chart
Chart tools
Chart is warming up
The all-time price history for BBLG has not been loaded yet. Try again in a moment.
Altman Z-Score
-18.41 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
P/E -0.5×
P/S 0.0×
P/B 0.3×
P/FCF -0.6×
EV/EBITDA 1.2×
EV/Sales 0.0×
FCF Yield -158.0%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -57.8%
ROIC -60.2%
ROA -53.6%
Revenue 0.0%
Operating Income 23.3%
EPS (diluted) 45.1%
Free Cash Flow 34.8%
Current Ratio 13.8×
Quick Ratio 13.8×
Debt / Equity 0.0×
Net Debt / EBITDA 1.7×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31